北京仲裁委员会裁定银河证券(06881.HK)可获回祥升投资购回交易金额及违约金
银河证券(06881.HK)公布,近日收到北京仲裁委员会出具的《裁决书》,裁决祥升投资支付公司截至4月底止购回交易金额4,560.55万元人民币(下同),并支付自5月1日起至实际支付完毕购回交易金额之日止,按年利率5.7%的标准计算的利息。
祥升投资向公司支付至4月底止的违约金127.28万元,及支付自5月1日起至实际支付完毕购回交易金额之日止,按每日万分之五的标准计算的违约金。
公司有权对祥升投资质押给公司的长生生物科技(002680.SZ)的974.87万股流通股股票折价或者以拍卖、变卖该等质押股票所得价款在上述第1项和第2项裁决范围内优先受偿。
祥升投资向公司支付律师费10万元,及驳回公司其他仲裁请求,另外祥升投资向公司支付公司代垫的仲裁费用30.63万元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.